IL6 and inflammatory bowel disease: This miRNA is associated with the inflammatory process as it was found to increase the expression of proinflammatory cytokines such as TNF-α and IL-6 and activate the NF-κB pathway, often associated with IBD pathogenesis [11,16,17].